Vynamic Insights provide unique perspectives on relevant healthcare industry topics and thought leadership to help leaders in healthcare innovate from strategy to execution.
OVERVIEW Medical Affairs is both a rewarding and challenging area in the evolving environment of drug development and launch readiness planning. Increased scientific, clinical, regulatory, and payer requirements to demonstrate clinical value and product differentiation in increasingly well-established therapeutic areas heightens the demand for an evidence package that clearly fulfills unmet medical need, and justifies …
From large healthcare systems and Integrated Delivery Networks to private practice offices and urgent care clinics, patients have numerous options for their care depending upon the urgency of their condition and their provider preferences. Inexplicably, each of these disparate care locations often have their own electronic health record (EHR) systems; even when part of the …
1. SPECIALTY DRUGS WILL ACCOUNT FOR 50% OF DRUG SPENDING IN 2018 Recently, CVS Caremark predicted that specialty drugs will account for 50% of drug spending in 2018, up from 30% in 2012. This explosion in revenue is due to a continued decline in revenue generated from blockbuster primary care products and from a ramp …
1. ACT NOW Healthcare executives need to prepare for not if, but when the standard of care shifts even more dramatically to the home. Home infusion provides the opportunity for efficient use of hospital days and effective management of scarce resources, and is a rare win-win for the provider industry. Whether it is the direct …
Abstract Many healthcare companies have attempted to use Program Management Offices (PMOs) to navigate transformational change. Unfortunately, traditional PMO models have fallen short in producing either realistic business cases and/or quality execution. The limitations of these models are insufficient for today’s dynamic healthcare business environment. To overcome this, Vynamic has designed the Strategic Transformation Office …
For life sciences companies, product launches are pivotal milestones in a product’s lifecycle and set a trajectory for the product’s financial performance over its life. Given the scale and potential impact of a life sciences product launch, getting it right really matters. These multi-year launch efforts involve cross-functional teams comprised of marketing, sales, manufacturing, market …
The proliferation of pharmaceutical savings card programs currently blanketing magazines, TV advertisements, and internet sites are ubiquitous for prescription drugs. While these offers seem like a great deal to patients and pharmaceutical companies, health plans and other payers warn that there are long-term implications. Perhaps the issue isn’t as clear cut as one might think. …
ABSTRACT Managing a population’s health can no longer fall solely at the hands of healthcare providers. One’s health is about more than just healthcare because it requires the interaction and integration of care across the entire health continuum, including multiple care settings and health disciplines, to tackle the numerous factors that impact a population’s health. …
ABSTRACT The use of telemedicine is growing, and it is being adopted through four primary channels: providers, payers, employers, and consumers. There are several distinct ways telemedicine is being used, including home visits, virtual visits, tele-ICU, acute care robots, and expert second opinions. Inconsistent state legislation and requirements will slow adoption if not modified. Telemedicine …
There are an increasing number of mergers taking place in the healthcare industry. Managing the integration of merged organizations requires deftly managing four often overlooked areas including communication, the integration team, critical path activities, and risks & issues. Merger activity across healthcare increased significantly in 2015 and is continuing to accelerate according to the Wall …
